A Phase I Study of the PK, Tissue Distribution and Metabolism of Small Molecule Inhibitors of Prostate Specific Membrane Antigen, 99mTc-MIP-1404 and 99mTc-MIP-1405, in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers
Latest Information Update: 07 Nov 2021
At a glance
- Drugs 99mTc MIP-1405 (Primary) ; Technetium tc 99m trofolastat (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Sponsors Molecular Insight Pharmaceuticals
Most Recent Events
- 24 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2014 New trial record